Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3536-3544

  Qin, Yimin ^a   Camoretti Mercado, Blanca ^a   Blokh, Lyubov ^a   Long, Catherine G ^a   Ko, Franklin D ^a   Hamann, Kimm J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; CASPASE 8; FAS ANTIBODY; FAS ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN BCL XL; SYNAPSIN I; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL STIMULATION; DOSE RESPONSE; DOWN REGULATION; EOSINOPHIL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036784631     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3536     Document Type: Article

References (64)

1. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
2. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
3. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
4. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-αB. Science 274:787.
5. Schulze-Osthoff, K., P. H. Krammer, and W. Droge. 1994. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:4587.
6. Rensing-Ehl, A., S. Hess, H. W. Loms Ziegler-Heitbrock, G. Riethmuller, and H. Engelmann. 1995. Fas/Apo-1 activates nuclear factor κB and induces interleukin-6 production. J. Inflamm. 45:161.
7. Ponton, A., M.-V. Clement, and I. Stamenkovic. 1996. The CD95 (APO-1/Fas) receptor activates NF-κB independently of its cytotoxic function. J. Biol. Chem. 271:8991.
8. Mandal, M., S. B. Maggirwar, N. Sharma, S. H. Kaufmann, S.-C. Sun, and R. Kumar. 1996. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-κB signaling pathway. J. Biol. Chem. 271:30354.
9. Packham, G., J. M. Lahti. B. E. Fee, J. M. Gawn, E. Coustan-Smith, D. Campana, I. Douglas, V. J. Kidd, S. Ghosh, and J. L. Cleveland. 1997. Fas activates NF-κB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-α. Cell Death Differ. 4:130.
10. Cheema, Z. F., S. B. Wade, M. Sata, K. Walsh, F. Sohrabji, and R. C. Miranda. 1999. Fas/Apo (apoptosis)-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-κB. J. Neurosci. 19:1754.
11. Landowski, T. H., M. C. Gleason-Guzman, and W. S. Dalton. 1997. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89:1854.
12. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
13. Mueller, C. M., and D. W. Scott. 2000. Distinct molecular mechanisms of Fas resistance in munne B lymphoma cells. J. Immunol. 165:1854.
14. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365:182.
15. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
16. Zandi. E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243.
17. Huxford, T., D. B. Huang, S. Malek, and G. Ghosh. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95:759.
18. Karin, M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18:6867.
19. Jobin, C., and R. B. Sartor. 2000. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am. J. Physiol. 278:C451.
20. Deveraux, Q. L., and J. C. Reed. 1999. IAP family proteins-suppressors of apoptosis. Genes Dev. 13:239.
21. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136
22. L. Mol. Cell. Biol. 20:2687.
23. + lymphocytes. J. Immunol. 165:1743.
24. Takahashi, R., Q. Deveraux, I. Tamm, K. Welsh, N. Assa-Mint, G. S. Salvesen, and J. C. Reed. 1998. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 273:7787.
25. Stehlik, C., R. de Martin, I. Kumabashiri, J. A. Schmid, B. R. Binder, and J. Lipp. 1998. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med. 188:211.
26. Paul, C. C., M. Tolber, S. Mahrer, A. Singh, M. J. Grace, and M. A. Baumann. 1993. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils. Blood 81:1193.
27. Baumann, M. A., and C. C. Paul. 1998. The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells 16:16.
28. Scaffidi, C., J. P. Medema, P. H. Krammer, and M. E. Peter. 1997. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 272:26953.
29. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Bets, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096.
30. Grisham, M. B., V. J. Palombella, P. J. Elliott, E. M. Conner, S. Brand, H. L. Wong, C. Pien, L. M. Mazzola, A. Destree, L. Parent, and J. Adams. 1999. Inhibition of NF-κB activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol. 300:345.
31. Neish, A. S., A. T. Gewirtz, H. Zeng, A. N. Young, H. E. Hobert, V. Karmali, A. S. Rao, and J. L. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289:1560.
32. Griscavage, J. M., S. Wilk, and L. J. Ignarro. 1996. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:3308.
33. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
34. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301.
35. Parmacek, M. S., A. J. Vora, T. Shen, E. Barr, F. Jung, and J. M. Leiden. 1992. Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow cardiac tropinin C gene. Mol. Cell. Biol. 12:1967.
36. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
37. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407:789.
38. Cohen, G. M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1.
39. Suliman, A., A. Lam, R. Datta, and R. K. Srivastana. 2001. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20:2122.
40. Seol, D.-W., J. Li, M.-H. Seol, S.-Y. Park, R. V. Talanian, and T. R. Billiar. 2001. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase 8 is required for TRAIL-induced apoptosis. Cancer Res. 61:1138.
41. Bargou, R. C., F. Emmerich, D. Krappmann, K. Bommert, M. Y. Mapara, W. Arnold, H. D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dorken. 1997. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:2961.
42. Clifton, D. R., R. A. Goss, S. K. Sahni, D. van Antwerp, R. B. Baggs, V. J. Marder, D, J. Silverman, and L. A. Sporn. 1998. NF-κB-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection. Proc. Natl. Acad. Sci. USA 95:4646.
43. Maggirwar, S. B., P. D. Sarmiere, S. Dewhurst, and R. S. Freeman. 1998. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons. J. Neurosci. 18:10356.
44. + bone marrow cell survival. Blood 93:3302.
45. Manos, E. J., and D. A. Jones. 2001. Assessment of tumor necrosis factor receptor and Fas signaling pathways by transcriptional profiling. Cancer Res. 61:433.
46. Arch, R. H., and C. B. Thompson. 1999. Lymphocyte survival-the struggle against death. Annu. Rev. Cell Dev. Biol. 15:113.
47. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866.
48. Yanagisawa, J., M. Takahashi, H. Kanki, H. Yano-Yanagisawa, T. Tazunoki, E. Sawa, T. Nishitoba, M. Kamishohara, E. Kobayashi, S. Kataoki, and T.-K. Sato. 1997. The molecular interaction of Fas and FAP-1: a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272:8539.
49. Li, Y., H. Kanki, T. Hachiya, T. Ohyama, S. Irie, G. Tang, J. Mukai, and T.-K. Sato. 2000. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells. Int. J. Cancer 87:473.
50. Maekawa, K., N. Imagawa, A. Naito, S. Harada, O. Yoshie, and S. Takagi. 1999. Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IκBα through interaction between the PDZI domain and ankyrin repeats. Biochem. J. 337:179.
51. Singh, S., B. G. Darnay, and B. B. Aggarwal. 1996. Site-specific tyrosine phosphorylation Of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271:31049.
52. Irie, S., T. Hachiya, S. Rabizadeh, W. Maruyama, Y. Li, J. C. Reed, D. E. Bredesen, and T.-A. Sato. 1999. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-κB activation. FEBS Lett. 460:191.
53. Nakai, Y., S. Irie, and T.-A. Sato. 2000. Identification of IκBα as a substrate of Fas-associated phosphatase-1. Eur. J. Biochem. 267:7170.
54. Wang, C.-Y., M. W. Mayo, R. G. Komeluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680.
55. Roy, N., Q. L. Deveraux, R. Takahashi, G. S. Salvesen, and J. C. Reed. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914.
56. Ruemmele, F. M., J. F. Beaulieu, J. O'Connell, M. W. Bennett, E. G. Seidman, and M. J. Lentze. 2002. The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of c1AP1 and 2. Biochem. Biophys. Res. Comm. 290:1308.
57. Suzuki, Y., Y. Nakabayashi, K. Nakata, J. C. Reed, and R. Takahashi. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J. Biol. Chem. 276:27058
58. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K.-M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
59. L. Proc. Natl. Acad. Sci, USA 96:14871.
60. Huang, D. C., J. Tschopp, and A. Strasser. 2000. Bcl-2 does not inhibit cell death induced by the physiological Fas ligand: implications for the existence of type I and type II cells. Cell Death Differ. 7:754.
61. Schmitz, I., H. Walczak, P. H. Krammer, and M. E. Peter. 2000. Differences between CD95 type I and II cells detected with the CD95 ligand. Cell Death Differ. 7:756.
62. L-expressing MCF7-Fas cells: role for the functional apoptosis regulator protein, J. Biol. Chem. 277:4351.
63. L inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-liked inhibitor-of-apoptosis protein. J. Biol. Chem. 277:11345.
64. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95:554.